A. Uluslararası hakemli dergilerde yayımlanan makaleler :

A1. M. Seker, A. Bilici, DO. Guler, BB. Ustaalioglu, H. Gozu, FY. Erkal, B. Sonmez, M. Karaduman, U. Kefeli, E. Yildirim, T. Salepci, M. Gumus, "Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?", Hepatogastroenterology, 58, 110-111, (2011), doi: 10.5754/hge10288.

A2. M. Seker, A. Bilici, BO. Ustaalioglu, B. Yilmaz, B. Ozturk, A. Unal, F. Dane, NY. Ozdemir, ET. Elkiran, ME. Kalender, M. Gumus, M. Benekli, "Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast", Arch Gynecol Obstet, 284, 405-409, (2011), doi: 10.1007/s00404-010-1683-y.

A3. M. Seker, A. Bilici, B. Sonmez, BB. Ustaalioglu, M. Gumus, H. Gozu, M. Sargin, A. Orcun, C. Gezen, M. Eser, N. Bildik, T. Salepci, "The association of serum adiponectin levels with histopathological variables in gastric cancer patients", Med Oncol, 27, 1319-1323, (2010), doi: 10.1007/s12032-009-9382-x.

A4. M. Seker, B. Ozdemir, A. Bilici, BB. Ustaalioglu, B. Sonmez, BE. Yilmaz, E. Kurnaz, M. Gumus, M. Yaylaci, "Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis", Onkologie, 33, 317-320, (2010). doi: 10.1159/000313853.

A5. M.Seker, BB. Ustaalioglu, A. Bilici, ME. Yildirim, U. Kefeli, NO. Barişik, I. Tamer, M. Gumus, "Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma", Leuk Res, 34, e160-163, (2010), doi: 10.1016/j.leukres.2010.02.013.

A6. M. Seker, BB. Ustaalioglu, A. Bilici, NI. Ozseker, A. Aksu, M. Gumus, "Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma", J BUON, 14, 726-727, (2009).

A7. M. Seker, A. Bilici, BO. Ustaalioglu, T. Salman, B. Sonmez, NA. Canpolat, T. Salepci, M. Gumus, M. Yaylaci, "Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma", Leuk Res, 33, e154-156, (2009), doi: 10.1016/j.leukres.2009.03.026.

A8. M. Seker, HI. Gozu, BB. Oven Ustaalioğlu, B. Sonmez, FY. Erkal, M. Kocak, NO. Barisik, E. Orbay, Sargin M, Sargin H, Boru UT, Yaylaci M, "Myasthenia gravis and autoimmune Addison disease in a patient with thymoma", Clin Lung Cancer, 10, 367-370, 2009.

A9. M. Seker, A. Sevinc, R. Yildiz, S. Cihan, MA. Kaplan, A. Gokdurnali, F. Dane, E. Yaman, H. Karaca, D. Colak , U. Uyeturk, A. Bilici, NY. Ozdemir, ME. Kalender, D. Uncu, T. Salepci, A. Isikdogan, M. Benekli, M. Ozkan, G. Gumus, U. Coskun, C. Camci, B. Oksuzoglu, S. Buyukberber; Anatolian Society of Medical Oncology (ASMO). "Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey", Hepatogastroenterology. 2013 Jun;60(124):768-75. doi: 10.5754/hge11666. Epub 2012 Nov 20.

A10. A. Bilici, BB. Ustaalioglu, M. Seker, U. Kefeli, N. Canpolat, B. Tekinsoy, S. Ozogur, M. Gumus, "The role of (18)F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?", Eur J Nucl Med Mol Imaging, 38, 64-73, (2011), doi: 10.1007/s00259-010-1611-1.

A11. BB. Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, M. Oncel, C. Gezen, M. Gumus, F. Demirelli, "The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients: Single Center Experience", Am J Clin Oncol, (2011), doi: 10.1097/COC.0b013e31822d9cd6.

A12. A. Bilici, BB. Ustaalioglu, S. Ercan, A. Orcun, M. Seker, T. Salepci, M. Gumus, "Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?", Cancer Chemother Pharmacol, 68, 309–316, (2011), 10.1007/s00280-010-1480-0.

A13. A. Bilici, F. Dane, M. Seker, BB. Ustaalioglu, M. Aliustaoglu, S. Temiz, C. Gezen, D. Yavuzer, G. Aksu, A. Mayadagli, M. Gumus, K. Uygun, NS. Turhal, "Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers", Dig Dis Sci, (2011), doi: 10.1007/s10620-011-1721-z.

A14. A. Bilici, K. Uygun, M. Seker, BB. Ustaalioglu, M. Aliustaoglu, S. Temiz, G. Aksu, C. Gezen, D. Yavuzer, S. Kaya, T. Salepci, A. Mayadagli, M. Gumus, "The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers", Onkologie, 33, 676-682, (2010), doi: 10.1159/000322215.

A15. A. Bilici, T. Salepci, F. Dane, M. Gumus, BB. Ustaalioglu, M. Seker, T. Salman, C. Turan, O. Unal, M. Yaylaci, "Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience", Arch Gynecol Obstet, 282, 417-425, (2010), doi: 10.1007/s00404-009-1330-7.

A16. A. Bilici, M. Seker, BB. Ustaalioglu, U. Kefeli, E. Yildirim, D. Yavuzer, FM. Aydin, T. Salepci, M. Oncel, M. Gumus, "Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection", Ann Surg Oncol, 17, 2037-2044, (2010), doi: 10.1245/s10434-010-1027-y.

A17. A. Bilici, BB. Ustaalioglu, M. Seker, N. Canpolat, B. Tekinsoy, T. Salepci, M. Gumus, "Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?", Eur J Nucl Med Mol Imaging, 37, 1259-1269, (2010), doi: 10.1007/s00259-010-1416-2.

A18. A. Bilici, BB. Ustaalioglu, M. Gumus, M. Seker, B. Yilmaz, U. Kefeli, E. Yildirim, B. Sonmez, T. Salepci, M. Kement, A. Mayadagli, "Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?", Onkologie, 33, 101–105, (2010), doi: 10.1159/000277927.

A19. A. Bilici, M. Seker, BB. Ustaalioglu, B. Yilmaz, A. Doventas, T. Salepci, M. Gumus, "Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer", Med Oncol, 27, 975-84, (2010), doi: 10.1007/s12032-009-9319-4.

A20. BB. Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, T. Salepci, O. Unal, M. Gumus, "A retrospective analysis of women’s chances to become pregnant after completion of chemotherapy: a single center experience", J BUON, 16, 349-352, (2011).

A21. B. Sonmez, M. Seker, A. Bilici, FY. Erkal, BB. Oven Ustaalioglu, M. Gumus, D. Ozturk Guler, M. Karaduman, C. Gezen, M. Eser, N. Bildik, T. Salepci, "Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?", J BUON, 16, 227-232, (2011).

A22. A. Sevinc, M. Seker, A. Bilici, NY. Ozdemir, R. Yildiz, BO. Ustaalioglu, ME. Kalender, F. Dane, H. Karaca, C. Gemici, M. Gumus, S. Buyukberber, "Co-existence of gastrointestinal stromal tumors with other primary neoplasms", Hepatogastroenterology, 58, 824-830, (2011).

A23. A. Bilici, M. Seker, BB. Ustaalioglu, N. Canpolat, T. Salepci, M. Gumus, "Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: "Report of First Case and F-18 FDG PET/CT Images", J Korean Med Sci, 26, 574-576, (2011), doi: 10.3346/jkms.2011.26.4.574.

A.24. F. Dane, M. Seker, PF. Yumuk, F. Gunduz, O. Peker, G. Basaran, NS Turhal, "Primary breast mantle cell lymphoma with atypical relapse patterns", J BUON, 16, 181-182, 2011.

A25. BB. Oven Ustaalioglu, A. Bilici, U. Kefeli, M. Seker, E. Yildirim, T. Salepci, M. Oncel, M. Kement, M. Gumus, "Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences", Oncology, 79, 105–111, (2010), doi: 10.1159/000320162.

A26. BB. Oven Ustaalioglu, U. Kefeli, A. Bilici, R. Ustaalioglu, M. Seker, F. Cinarel, I. Dogusoy, "F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer", Clin Nucl Med, 36, 367-369, (2011).

A27. M. Gumus, BO. Ustaalioglu, M. Garip, E. Kiziltan, A. Bilici, M. Seker, B. Erkol, T. Salepci, A. Mayadagli, NS. Turhal, "Factors that Affect Patients’ Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients", Breast Care (Basel), 5, 164-168, (2010), doi: 10.1159/000314266.

A28. BB. Ustaalioglu, M. Gumus, A. Unal, K. Cayir, O. Sever, A. Bilici, ET. Elkiran, H. Karaca, M. Benekli, A. Karaoglu, M.Seker, "Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences", Int J Gynecol Cancer, 20, 698-703, (2010), doi: 10.1111/IGC.0b013e3181daaf3e.

A29. BB. Oven Ustaalioglu, M. Gumus, A. Bilici, M. Seker, R. Ustaalioglu, U. Kefeli, T. Salepci, N. Canpolat, A. Mayadagli, I. Dogusoy, "Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience", J BUON, 15, 529-536, (2010).

A30. M. Aliustaoglu, A. Bilici, M. Seker, F. Dane, M. Gocun, V. Konya, BB. Ustaalioglu, M. Gumus, "The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer", Hepatogastroenterology, 57, 640-645, (2010).

A31. U. Kefeli, A. Bilici, BB. Ustaalioglu, AU. Kefeli, ME. Yildirim, M. Seker, M. Gumus, "A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy", Arch Gynecol Obstet, 283, 405-407, (2011), doi: 10.1007/s00404-010-1519-9.

A32. T. Salman, M. Seker, A. Bilici, BB Oven Ustaalioglu, M. Gumus, M. Yaylaci, "Lung cancer presenting with extreme leukocytosis", J BUON, 15, 193, (2010).

A33. U. Kefeli, S. Kaya, BO. Ustaalioglu, A. Bilici, AU. Kefeli, ME. Yildirim, M. Seker, B. Yilmaz, T. Salepci, K. Uygun, M. Gumus, "Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience", Med Oncol, 28, 661-666, (2011), doi:10.1007/s12032-010-9504-5.

A34. A. Bilici, BB. Ustaalioglu, M. Seker, N. Canpolat, M. Gumus, "F-18 FDG PET/CT Imaging in Recurrent Mantle Cell Lymphoma Presenting With Cauda Equina Syndrome", Clin Nucl Med, 35, 211-212, (2010).

A35. A. Bilici, BB. Ustaalioglu, M. Seker, S. Kayahan, "Case Report: Soft Tissue Metastasis from Immature Teratoma of the Testis: Second Case Report and Review of the Literature", Clin Orthop Relat Res, 468, 2541-2544, (2010), doi: 10.1007/s11999-009-1173-3.

A36. BB. Ustaalioglu, M. Seker, A. Bilici, N. Canpolat, E. Yildirim, U. Kefeli, R. Ustaalioglu, BE. Yilmaz, T. Salepci, N. Ozdemir, M. Gumus, "The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma", Med Oncol, 28, 258-264, (2011), doi: 10.1007/s12032-010-9446-y.

A37. M. Aliustaoglu, A. Bilici, BB. Ustaalioglu, V. Konya, M. Gucun, M. Seker, M. Gumus, "The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment", Med Oncol, 27, 1060-1065, (2010), doi: 10.1007/s12032-009-9335-4.

A38. BB. Ustaalioglu, A. Bilici, M. Seker, N. Canpolat, N. Ozdemir, T. Salepci, M. Gumus, "Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report", Leuk Res, 34, e108-110, (2010), doi: 10.1016/j.leukres.2009.10.020.

A39. BB. Ustaalioglu, M. Gumus, A. Bilici, M. Seker, F. Dane, T. Salepci, T. Salman, M. Aliustaoglu, M. Eser, C. Gezen, M. Yaylaci, NS. Turhal, "Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience", Med Oncol, 27, 454-458, (2010), doi: 10.1007/s12032-009-9233-9.

A40. M. Aliustaoglu, A. Bilici, M. Gumus, AT. Colak, G. Baloglu, R. Irmak, M. Seker, BB. Ustaalioglu, T. Salman, B. Sonmez, T. Salepci, M. Yaylaci, "Preoperative serum leptin levels in patients with breast cancer", Med Oncol, 27, 388-391, (2010), doi: 10.1007/s12032-009-9222-z.

A41. T. Salepci, M. Seker, H. Uyarel, M. Gumus, A. Bilici, BB. Ustaalioglu, A. Ozturk, B. Sonmez, A. Orcun, M. Ozates, R. Irmak, M. Yaylaci, "5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels", Med Oncol, 27, 416-420, (2010), doi: 10.1007/s12032-009-9226-8.

A42. A. Bilici, B. Karadag, A. Doventas, M. Seker, "Gastric pneumatosis intestinalis associated with malignancy: An unusual case report", World J Gastroenterol, 15, 758-760, (2009), doi: 10.3748/wjg.15.758.

A43. BB. Ustaalioglu, A. Bilici, M. Seker, T. Salepci, S. Keser, M. Gumus, "Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor", J BUON, 14, 727-728, (2009).

A44. T. Salepci, H. Yazici, F. Dane, E. Topuz, N. Dalay, H. Onat, F. Aykan, M. Seker, A. Aydiner, "Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients", J BUON, 14, 495-499, (2009).

A45. BB. Ustaalioglu, A. Bilici, M. Seker, T. Salman, M. Gumus, NO. Barisik, T. Salepci, M. Yaylaci, "Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy", Onkologie, 32, 424-426, (2009), doi: 10.1159/000218367.

A46. BB. Ustaalioglu, A. Bilici, M. Seker, M. Gumus, N. Ozdemir, T. Salman, M. Yaylaci, "Bilateral primary small lymphocytic lymphoma of the lacrimal sac and review of the literature", Leuk Res, 33, e184-185, (2009), doi: 10.1016/j.leukres.2009.05.006.

A47. T. Salepci, M. Seker, E. Kurnaz, DO. Guler, A. Bilici, F. Dane, M. Aliustaoglu, EB. Atesoglu, M. Gumus, M. Yaylaci, "Conjunctival malt lymphoma successfully treated with single agent rituximab therapy", Leuk Res, 33, e10-13, (2009), doi: 10.1016/j.leukres.2008.05.018.

A48. M. Kocak, A. Ozkan, A. Mayadagli, C. Parlak, A. Bilici, M. Seker, BB. Oven Ustaalioglu, M. Gumus, M. Eren, SG. Karabulut, F. Oruc, "Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: a single-institution review of two different regimens", Clin Lung Cancer, 10, 124-129, (2009), doi: 10.3816/CLC.2009.n.016.

A49. A. Bilici, M. Seker, BB. Ustaalioglu, T. Salman, AA. Igdem, E. Celik, T. Salepci, M. Gumus, M. Yaylaci, "Metastatic Renal Hemangiopericytoma: A Rare Case Report". Arch Oncol, 17, 32-35, (2009), doi: 10.2298/AOO0902032B.

A50. M. Koldas, M. Gummus, M. Seker, H. Seval, K. Hulya, F. Dane, A. Kural, A. Gumus, T. Salepci T, NS. Turhal, "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer", Clin Lung Cancer, 2, 112-115, (2008).

A51. H. Sargin, M. Sargin, H. Gozu, A. Orcun, G. Baloglu, M. Ozisik, M. Seker, OU. Bayramicli , "Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients? " World J Gastroenterol, 37, 5874-5877, (2005).

A52. I. Tamer, M. Sargin, H. Sargin, M. Seker, E. Babalik, M. Tekce, A. Yayla, "The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism", Endocr J, 4, 421-425, (2005).

A53. Bilici A, Inanc M, Ulas A, Akman T, Seker M, Babacan NA, Inal A, Bal O, Koral L, Sevinc A, Tufan G, Elkiran ET, Ustaalioglu BB, Yavuzsen T, Alkis N, Ozkan M, Gumus M. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology. Asian Pac J Cancer Prev. 2013;14(11):6493-9

A54. Oven Ustaalioglu BB, Bilici A, Yilmaz BE, Aliustaoglu M, Seker M, Vardar F, Gumus M. Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey. Breast Care (Basel). 2014 May;9(2):123-7. doi: 10.1159/000360929.

A55. Uygun K, Bilici A, Kaya S, Oven Ustaalioglu BB, Yildiz R, Temiz S, Seker M, Aksu G, Cabuk D, Gumus M. XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions. Asian Pac J Cancer Prev. 2013;14(4):2283-8

A56. Ustaalioglu BB, Bilici A, Ercan S, Seker M, Orcun A, Gumus M. The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer. Med Oncol. 2013 Jun;30(2):551. doi: 10.1007/s12032-013-0551-6. Epub 2013 Mar 28.

A57. Kaplan MA, Isikdogan A, Gumus M, Arslan UY, Geredeli C, Ozdemir N, Koca D, Dane F, Suner A, Elkiran ET, Kucukoner M, Seker M, Helvaci K, Guler T, Uncu D, Inal A, Yildiz R. Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology. J Pediatr Hematol Oncol. 2013 Mar;35(2):83-9. doi: 10.1097/MPH.0b013e31827e7f20.

A58. Kefeli U, Buyuberber S, Akyol M, Yildiz R, Kaplan MA, Ciltas A, Sevinc A, Karaca H, Seker M, Ozdemir N, Alacacioglu A, Coskun U, Isikdogan A, Dane F, Gumus M, Ozkan M, Suner A, Tarhan MO, Benekli M. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience. Hepatogastroenterology. 2013 Jun;60(124):647-52.

A59. Bilici A, Yapici HS, Ercan S, Seker M, Ustaalioglu BB, Salman T, Orcun A, Gumus M. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features? J BUON. 2012 Jul-Sep;17(3):502-7

A60. Bilici A, Ustaalioglu BB, Ercan S, Seker M, Yilmaz BE, Orcun A, Gumus M. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer. Tumour Biol. 2012 Dec;33(6):2201-8. doi: 10.1007/s13277-012-0481-5. Epub 2012 Aug 14.

A61. Elkiran ET, Kaplan MA, Sevinc A, Aksoy S, Demirci U, Seker M, Harputluoglu H, Ozdemir NY, Isik F, Ulas A, Inanc M, Arslan UY, Dogu GG, Isikdogan A, Buyukberber S; Anatolian Society of Medical Oncology Group. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients. Med Oncol. 2012 Dec;29(5):3147-54. doi: 10.1007/s12032-012-0276-y. Epub 2012 Jun 22.

A62. Oven Ustaalioglu B, Bilici A, Ercan S, Orcun A, Seker M, Ozkan A, Ustaalioglu R, Gumus M. Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls. Clin Transl Oncol. 2012 May;14(5):356-61. doi: 10.1007/s12094-012-0808-0.

A63. Bilici A, Salman T, Oven Ustaalioglu BB, Unek T, Seker M, Aliustaoglu M, Gezen C, Unek T, Yavuzer D, Unlu M, Gumus M, Yilmaz U. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy. J Surg Res. 2013 Mar;180(1):e1-9. doi: 10.1016/j.jss.2012.03.035. Epub 2012 Apr 11.

A64. Bilici A, Ustaalioglu BB, Yavuzer D, Seker M, Mayadagli A, Gumus M. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy. Dig Dis Sci. 2012 Jun;57(6):1568-75. doi: 10.1007/s10620-012-2076-9. Epub 2012 Feb 14.

A65. Bilici A, Sonkaya A, Ercan S, Ustaalioglu BB, Seker M, Aliustaoglu M, Orcun A, Gumus M. The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors? Tumour Biol. 2014 Oct 9.

A66. Ozcelik M, Seker M, Eraslan E, Koca S, Yazilitas D, Ercelep O, Ozaslan E, Kaya S, Hacibekiroglu I, Menekse S, Aksoy A, Taskoylu BY, Varol U, Arpaci E, Ciltas A, Oksuzoglu B, Zengin N, Gumus M, Aliustaoglu M.Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology. Tumour Biol. 2016 Apr;37(4):5231-7. doi: 10.1007/s13277-015-4359-1. Epub 2015 Nov 10.

A67. Mehmet K, Sener C, Uyeturk U, Seker M, Tastekin D, Tonyali O, Balakan O, Yazici OK, Urakci Z, Isikdogan A, Ozdemir N, Inal A, Kaplan MA, Suner A, Dal S, Uncu D, Gumus M, Boruban MC, Oksuzoglu B, Ayyildiz O, Benekli M. Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology.Contemp Oncol (Pozn). 2014;18(4):273-8. doi: 10.5114/wo.2014.40556. Epub 2014 Jul 22.

A68. Dinc NS, Aydın K, Odabas H, Ercelep O, Tufan G, Seker M, Yasar N, Aydin D, Yuksel S, Mert A, Ozcelik M, Korkmaz T, Yildiz R, Aliustaoglu M, Mayadagli A, Dane F, Gumus M. Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer. Oncol Res Treat. 2016;39(3):130-4. doi: 10.1159/000444272. Epub 2016 Feb 23.

A69. Seker M, Aydin D, Bilici A, Yavuzer D, Ozgun MG, Ozcelik M, Aydin O, Aliustaoglu M.
Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy. Oncol Res Treat. 2017;40(4):185-190. doi: 10.1159/000456620. Epub 2017 Mar 3.

A70. Kunduz E, Seri N KR, Seker M. Scalp recurrence of cholangiocarcinoma after curative hepatectomy: A report of two cases. Mol Clin Oncol. 2017 Dec;7(6):1122-1124. doi: 10.3892/mco.2017.1467. Epub 2017 Oct 23.

A71. Bilici A, Selcukbiricik F, Seker M, Oven BB, Olmez OF, Yildiz O, Olmuscelik O, Hamdard J, Acikgoz O, Cakir A, Kapran Y, Balik E, Oncel M. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy. Oncol Res Treat. 2019;42(4):209-216. doi: 10.1159/000496746. Epub 2019 Mar 14.

A72. Turk HM, Aliyev A, Celik RS, Seker M, Coban E, Demir T, Baydas T, Kocyigit A. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.

Curr Probl Cancer. 2020 Feb;44(1):100497. doi: 10.1016/j.currproblcancer.2019.06.009. Epub 2019 Jul 29.

A73. Sekerci A, Turk HM, Demir T, Seker M, Akcakaya A, Arici DS. Clinicopathological Features of Gastroenteropancreatic Neuroendocrine Neoplasms. J Coll Physicians Surg Pak. 2020 Aug;30(8):863-867. doi: 10.29271/jcpsp.2020.08.863.

A74. Demir T, Aliyev A, Beşiroğlu M, Araz M, Köstek O, Sakin A, Shbair ATM, Çoban G, Ersöz C, Şeker M, Türk HM. Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? Curr Probl Cancer. 2021 Feb;45(1):100619. Doi10.1016/j.currproblcancer.2020.100619. Epub 2020 Aug 6.

A75. Acikgoz O, Cakan B, Demir T, Bilici A, Oven BB, Hamdard J, Olmuscelik O, Olmez OF, Seker M, Yildiz O. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer. Medicine (Baltimore). 2021 Nov 5;100(44):e27712. doi: 10.1097/MD.0000000000027712.

A76. Topcu A, Yasin AI, Shbair AT, Besiroglu M, Simsek M, Sucuoglu Z, Yurtsever I, Gucin Z, Seker M, Turk HM. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer. J Oncol Pharm Pract. 2022 Jan;28(1):242-246. doi: 10.1177/10781552211027931. Epub 2021 Jun 24.

A77. Gultekin MA, Peker AA, Oktay AB, Turk HM, Cesme DH, Shbair ATM, Yilmaz TF, Kaya A, Yasin AI, Seker M, Mayadagli A, Alkan A. Differentiation of lung and breast cancer brain metastases: Comparison of texture analysis and deep convolutional neural networks. J Clin Ultrasound. 2023 Nov-Dec;51(9):1579-1586. doi: 10.1002/jcu.23558. Epub 2023 Sep 9.

A78. Yasin AI, Uluganyan M, Isleyen ZS, Topcu A, Shbair AT, Simsek M, Besiroglu M, Ersoy YE, Türk HM, Seker M. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram.

Support Care Cancer. 2024 Jul 8;32(8):492. doi: 10.1007/s00520-024-08702-0.PMID: 38976108

A79. Topcu A, Yasin AI, Besiroglu M, Sucuoglu Isleyen Z, Alaca Topcu Z, Simsek M, Turk HM, Seker M, Soysal P. Prevalence and co-incidence of geriatric syndromes according to the ECOG performance status in older cancer patients. Front Med (Lausanne). 2024 Feb 19;11:1331246. doi: 10.3389/fmed.2024.1331246. eCollection 2024.PMID: 38439897

A80. Kutlu Y, Cekin R, Aydin SG, Shbair ATM, Bilici A, Arici S, Oven BB, Acikgoz O, Ozcan E, Olmez OF, Cakir A, Seker M. Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer. Curr Probl Cancer. 2024 Jun;50:101102. doi: 10.1016/j.currproblcancer.2024.101102. Epub 2024 May 11.PMID: 38735211

A81. Hamdard J, Bilici A, Sakin A, Kahraman S, Yasin AI, Kalaci E, Gokmen I, Acikgoz O, Kutlu Y, Sendur MAN, Olmez OF, Seker M. Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience. J Chemother. 2025 May;37(3):268-277. doi: 10.1080/1120009X.2024.2358458. Epub 2024 May 27.

Prof. Mesut ŞEKER, M.D.